News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
654,685 Results
Type
Article (48209)
Company Profile (137)
Press Release (606325)
Multimedia
Podcasts (75)
Webinars (17)
Section
Business (180851)
Career Advice (2652)
Deals (32404)
Drug Delivery (113)
Drug Development (78154)
Employer Resources (150)
FDA (16801)
Job Trends (13625)
News (316076)
Policy (31101)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (2628)
Academic (1)
Accelerated approval (35)
Adcomms (33)
Allergies (144)
Alliances (46650)
ALS (180)
Alzheimer's disease (1742)
Antibody-drug conjugate (ADC) (299)
Approvals (17015)
Artificial intelligence (523)
Autoimmune disease (162)
Automation (34)
Bankruptcy (338)
Best Places to Work (10821)
BIOSECURE Act (20)
Biosimilars (183)
Biotechnology (91)
Bladder cancer (149)
Brain cancer (61)
Breast cancer (615)
Cancer (4744)
Cardiovascular disease (402)
Career advice (2238)
Career pathing (37)
CAR-T (284)
CDC (48)
Celiac Disease (2)
Cell therapy (759)
Cervical cancer (33)
Clinical research (67057)
Collaboration (1714)
Company closure (3)
Compensation (626)
Complete response letters (70)
COVID-19 (2468)
CRISPR (90)
C-suite (852)
Cystic fibrosis (153)
Data (6152)
Decentralized trials (1)
Denatured (22)
Depression (151)
Diabetes (496)
Diagnostics (6238)
Digital health (46)
Diversity (9)
Diversity, equity & inclusion (36)
Drug discovery (266)
Drug pricing (169)
Drug shortages (24)
Duchenne muscular dystrophy (236)
Earnings (75313)
Editorial (61)
Employer branding (17)
Employer resources (139)
Events (91343)
Executive appointments (996)
FDA (19948)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (23)
Funding (1457)
Gene editing (197)
Generative AI (49)
Gene therapy (623)
GLP-1 (964)
Government (4284)
Grass and pollen (8)
Guidances (381)
Healthcare (17571)
HIV (64)
Huntington's disease (45)
IgA nephropathy (85)
Immunology and inflammation (244)
Immuno-oncology (57)
Indications (107)
Infectious disease (2739)
Inflammatory bowel disease (192)
Inflation Reduction Act (10)
Influenza (116)
Intellectual property (254)
Interviews (497)
IPO (15219)
IRA (43)
Job creations (3157)
Job search strategy (1833)
JPM (61)
Kidney cancer (17)
Labor market (61)
Layoffs (487)
Leadership (36)
Legal (6758)
Liver cancer (94)
Longevity (14)
Lung cancer (640)
Lymphoma (372)
Machine learning (41)
Management (55)
Manufacturing (740)
MASH (162)
Medical device (12786)
Medtech (12833)
Mergers & acquisitions (18200)
Metabolic disorders (1260)
Multiple sclerosis (167)
NASH (16)
Neurodegenerative disease (347)
Neuropsychiatric disorders (98)
Neuroscience (3050)
Neurotech (1)
NextGen: Class of 2026 (6168)
Non-profit (4735)
Now hiring (35)
Obesity (590)
Opinion (296)
Ovarian cancer (161)
Pain (203)
Pancreatic cancer (225)
Parkinson's disease (299)
Partnered (35)
Patents (504)
Patient recruitment (501)
Peanut (56)
People (54079)
Pharmaceutical (40)
Pharmacy benefit managers (26)
Phase 1 (20676)
Phase 2 (29549)
Phase 3 (22214)
Pipeline (5235)
Policy (271)
Postmarket research (2368)
Preclinical (8795)
Press Release (56)
Prostate cancer (232)
Psychedelics (53)
Radiopharmaceuticals (268)
Rare diseases (904)
Real estate (5041)
Recruiting (68)
Regulatory (24532)
Reports (33)
Research institute (2374)
Resumes & cover letters (443)
Rett syndrome (28)
RNA editing (17)
RSV (76)
Schizophrenia (156)
Series A (241)
Series B (177)
Service/supplier (4)
Sickle cell disease (98)
Special edition (19)
Spinal muscular atrophy (172)
Sponsored (43)
Startups (3310)
State (2)
Stomach cancer (17)
Supply chain (93)
Tariffs (66)
The Weekly (52)
Vaccines (986)
Venture capital (89)
Weight loss (384)
Women's health (82)
Worklife (18)
Date
Today (94)
Last 7 days (568)
Last 30 days (2008)
Last 365 days (28594)
2026 (3234)
2025 (28845)
2024 (33090)
2023 (37498)
2022 (48362)
2021 (52418)
2020 (50987)
2019 (44135)
2018 (33576)
2017 (31205)
2016 (29800)
2015 (34786)
2014 (26938)
2013 (22648)
2012 (24233)
2011 (24859)
2010 (23265)
Location
Africa (840)
Alabama (78)
Alaska (6)
Arizona (236)
Arkansas (12)
Asia (40260)
Australia (6775)
California (10133)
Canada (3186)
China (1116)
Colorado (446)
Connecticut (477)
Delaware (302)
Europe (90077)
Florida (1607)
Georgia (325)
Hawaii (3)
Idaho (57)
Illinois (830)
India (62)
Indiana (500)
Iowa (21)
Japan (427)
Kansas (124)
Kentucky (34)
Louisiana (27)
Maine (72)
Maryland (1268)
Massachusetts (7201)
Michigan (315)
Minnesota (547)
Mississippi (6)
Missouri (131)
Montana (33)
Nebraska (27)
Nevada (117)
New Hampshire (77)
New Jersey (2873)
New Mexico (24)
New York (2801)
North Carolina (1344)
North Dakota (10)
Northern California (4881)
Ohio (319)
Oklahoma (20)
Oregon (37)
Pennsylvania (2063)
Puerto Rico (25)
Rhode Island (40)
South America (1147)
South Carolina (63)
South Dakota (1)
Southern California (4042)
Tennessee (164)
Texas (1663)
United States (36751)
Utah (315)
Vermont (1)
Virginia (257)
Washington D.C. (74)
Washington State (874)
West Virginia (3)
Wisconsin (111)
Wyoming (2)
654,685 Results for "international foundation for functional gastrointestinal disorders".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Functional Force: Precision Platforms Disrupt the 2026 Tumor Landscape
January 19, 2026
·
11 min read
Pharm Country
Salix in Collaboration with The U.S. Pain Foundation and the International Foundation for Gastrointestinal Disorders Establish the Inaugural Opioid-Induced Constipation (OIC) Awareness Day
Salix Pharmaceuticals, the gastroenterology division of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), The U.S. Pain Foundation (USPF), and The International Foundation for Gastrointestinal Disorders (IFFGD) today announced they are joining forces to declare Tuesday, Dec. 5, Opioid-Induced Constipation (OIC) Awareness Day.
December 5, 2023
·
4 min read
Funding
Novo Foundation Pumps $850M Into Denmark, Europe to Bolster Innovation
The Novo Nordisk Foundation’s funds will go toward supporting early-stage companies working in “human health, planetary health and societal resilience.”
January 16, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Cepheid Receives FDA Clearance for Xpert® GI Panel to Support Broad Detection of Gastrointestinal Pathogens
January 20, 2026
·
4 min read
Press Releases
Renexxion Ireland Ltd. Announces Issuance of Sixth New U.S. Patent Covering New Naronapride Trihydrate Formulation, Dosage Forms, and Treatment of GI Disorders
January 8, 2026
·
3 min read
C-suite
UPDATE: Novo Foundation Completes Board Takeover After Shareholder Pushback
“As the future chair I will attend to the interests of not only the Novo Nordisk Foundation but all shareholders of the company,” incoming chair and former Novo Nordisk CEO Lars Rebien Sørensen said at the meeting held Friday.
November 14, 2025
·
5 min read
·
Annalee Armstrong
Press Releases
Jazz Pharmaceuticals to Present Pivotal Phase 3 Results of Ziihera® (zanidatamab-hrii) Combinations in First-Line HER2-Positive Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma at the 2026 ASCO Gastrointestinal Cancers Symposium
Late-breaking HERIZON-GEA-01 presentation highlights the expanding clinical profile of Ziihera across HER2-driven gastrointestinal cancers Jazz to host investor webcast on Friday, January 9, 2026, to review data
December 2, 2025
·
15 min read
Press Releases
ACCENT DATA PRESENTED AT 2026 ASCO GASTROINTESTINAL CANCER SYMPOSIUM
January 13, 2026
·
3 min read
Press Releases
Amplia Therapeutics to Present at 2026 ASCO Gastrointestinal Cancers Symposium
December 24, 2025
·
2 min read
Press Releases
Veru to Present at The Society on Sarcopenia, Cachexia, and Wasting Disorders 18th International Conference and Regulatory and Clinical Trials Update Regulatory Workshop
December 4, 2025
·
11 min read
1 of 65,469
Next
